Ecolab Inc. announced today it reached an agreement to acquire the CID Lines group (“the Group”), from the IK VII Fund, advised by IK Investment Partners (IK), and the other shareholders. Completion of the transaction is subject to customary closing conditions, including approvals from applicable competition authorities. CID Lines is a hygiene and health solutions provider, principally focused on the animal health industry.
Founded in Belgium in 1989, CID Lines established itself as a leader in disinfectants for combatting infectious animal diseases. Today, the Group’s product range includes a variety of veterinary medicinal products as well as an extensive range of high-quality, branded biosecurity solutions for disinfection and cleaning procedures in farming environments.
Since partnering with CID Lines in January 2016, IK has supported the execution of a successful strategy that has realised continued strong growth. Through its expanding network, CID Lines serves customers across the globe and continues to enhance its base through its best-in-class commercial capabilities in combination with its excellent research & development and registration capabilities.
Remko Hilhorst, Managing Partner at IK Investment Partners and advisor to the IK VII Fund, commented: “CID Lines has made tremendous progress since we first partnered with them in 2016, cementing their position as a leader in the increasingly important market for biosecurity and immunity products that support reduced use of antibiotics in farm animals. We are grateful to have worked with such a dedicated team of professionals at CID Lines to help the business successfully expand its reach and product range. We wish them every success in the future and look forward to seeing how the Company develops.”
Koen Brutsaert, founder and CEO at CID Lines commented: “CID Lines showed excellent growth the last three years. The drivers behind this growth were continued investments in new products, registrations and our salesforce. IK has been very supportive of these investments in our growth, and we would like to thank them for this support.”
For further questions, please contact:
IK Investment Partners
Remko Hilhorst, Managing Partner
+31 208 909210
About IK Investment Partners
IK Investment Partners (“IK”) is a Pan-European private equity firm focused on investments in the Nordics, DACH region, France, and Benelux. Since 1989, IK has raised more than €10 billion of capital and invested in over 130 European companies. IK funds support companies with strong underlying potential, partnering with management teams and investors to create robust, well-positioned businesses with excellent long-term prospects. For more information, visit www.ikinvest.com
About CID Lines
Founded in Belgium in 1989, CID established itself as a leader in disinfectants for combatting infectious animal diseases. Today, the Group’s product range includes a variety of veterinary medicinal products as well as an extensive range of high-quality, branded biosecurity solutions for disinfection and cleaning procedures in farming environments.
